← Back to Search

Sleep Apnea Self-Management Program for Obstructive Sleep Apnea (ImPRESS Trial)

N/A
Waitlist Available
Led By Carl J Stepnowsky, Jr., PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
being newly prescribed an OSA therapy
having chronic symptoms per screening symptom checklist
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights

ImPRESS Trial Summary

This trial is examining a new strategy for increasing adherence with PAP therapy by having patients adjust their own pressure settings.

Eligible Conditions
  • Obstructive Sleep Apnea

ImPRESS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have recently started using a therapy for obstructive sleep apnea.
Select...
You have ongoing symptoms that are listed in the screening checklist.
Select...
You can speak and understand English well.

ImPRESS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Treatment Adherence

ImPRESS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Individualized Pressure AdjustmentExperimental Treatment1 Intervention
Additional education and support that will allow them to adjust their PAP pressures
Group II: Sleep Apnea Self-Management ProgramActive Control1 Intervention
Protocol-based sleep apnea and CPAP education and support
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sleep Apnea Self-Management Program
2018
Completed Phase 3
~510

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,605 Previous Clinical Trials
3,305,326 Total Patients Enrolled
Carl J Stepnowsky, Jr., PhDPrincipal InvestigatorVA San Diego Healthcare System, San Diego, CA
1 Previous Clinical Trials
240 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current enrollment of participants for this trial?

"Affirmative. The details on clinicaltrials.gov indicate that this medical research is currently recruiting patients, with an initial posting date of October 1st 2018 and a last update being made on June 22nd 2022. 275 participants are needed from one particular site for the trial to be successful."

Answered by AI

Are there any available openings for participants in this research?

"At present, this clinical trial is actively recruiting participants. It was originally posted on October 1st 2018 and most recently updated on June 22nd 2022 according to clinicialtrials.gov."

Answered by AI

What are the eligibility criteria for participating in this experiment?

"This clinical trial seeks 275 participants who suffer from sleep apnea, obstructive type and are aged between 18 and 70. To be eligible for the study these criteria must be met."

Answered by AI

Is this research endeavor open to enrollees who are 65 years and older?

"This clinical trial is open to individuals aged 18-70. Separately, there are 48 trials for minors and 235 studies available for those over 65 years old."

Answered by AI
~42 spots leftby Mar 2025